TEAD vs WST · rev $550.6M vs P/E 35, rev $1.72B
Teads B.V. (TEAD) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Teads B.V. (TEAD) is a internet content & information company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported TEAD revenue for 2026-06-30 was $550.6M. Net income was -$81.3M. TEAD currently screens at market cap $240.5M.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
TEAD currently screens at market cap $240.5M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the TEAD and WST stock pages for the full models.
Not investment advice.